Shares of Creo Medical Group PLC (LON:CREO – Get Free Report) traded up 1.2% during trading on Monday . The stock traded as high as GBX 29.10 ($0.38) and last traded at GBX 29.10 ($0.38). 85,367 shares were traded during mid-day trading, a decline of 85% from the average session volume of 588,259 shares. The stock had previously closed at GBX 28.75 ($0.38).
Creo Medical Group Price Performance
The firm has a market cap of £105.28 million, a P/E ratio of -415.71 and a beta of 0.86. The firm’s fifty day simple moving average is GBX 30.05 and its 200 day simple moving average is GBX 33.37. The company has a debt-to-equity ratio of 13.88, a quick ratio of 2.19 and a current ratio of 3.83.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
See Also
- Five stocks we like better than Creo Medical Group
- What is a Special Dividend?
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- What is a Bond Market Holiday? How to Invest and Trade
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- What is Insider Trading? What You Can Learn from Insider Trading
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
